News

Apply for a share of up to £25 million for ambitious or disruptive R&D innovations

Published on: 02/07/2019

Apply for a share of up to £25 million for ambitious or disruptive R&D innovations
Funding
Member News, Funding news

Secure the funding you need to progress your projects towards commercialisation.

We’re looking for game changing, disruptive, and innovative companies to partner with for the Innovate UK Smart Grants: April 2019.

Summary

Opportunity to apply for a share of up to £25 million to deliver ambitious or disruptive R&D innovations with significant potential for impact on the UK economy.

Closes: Wednesday 24th July 2019
OrganisationInnovate UK
GuidelinesRead the full competition details >

Why partner with the Medicines Discovery Catapult?

  • Our experienced commercial and scientific teams have connections across industry, academia, finance, government, and research networks – we can help take your projects further towards commercial viability.
  • We have specialist grant writing expertise to work with you in crafting top quality grant applications.
  • Our team have a wealth of industrial and academic expertise applied to drug discovery, complex cell models, assay development, biomarker identification, and validation.
  • You’ll have supported access, with specialist expertise, to cutting edge technologies including multi-omics capabilities, mass spec quantitationmass spec imaging, and organ-on-a-chip capabilities.
  • Our team are experts in translating analytical methodologies that are sensitive, specific, and robust for clinical utility.
  • Our Informatics team have deep expertise in natural language processing, data analysis, machine learning, cheminformatics, and bioinformatics.
  • We can providing access to information thats not readily available around target validation, drug target interaction, and downstream consequences of engagement.
  • We can help unlock access to appropriately consented patient Samples & Data.
  • We’ll give you access to a network of clinical, academic, and industry experts via Virtual R&D.

NEWS​

Related News

Open innovation challenge advances clinical data capture in Switzerland

28 Aug 2025
The Digital Health Nation Innovation Booster, powered by Innosuisse and led by DayOne, launched an Open Innovation Challenge to address fragmented, in...

EVITA joins HECADE: Strengthening Europe’s voice for hereditary cancer patients through collaboration

28 Aug 2025
EVITA, a Portuguese non-profit supporting individuals affected by hereditary cancer, has officially joined HECADE, a European network of patient organ...

ZimSmart Villages Championing Universal Health Access in Zimbabwe

27 Aug 2025
By harnessing the power of telehealth and digital innovation, ZimSmart Villages is not just bridging the gaps in Zimbabwe's healthcare system; it is b...

Germany – Medical Valley EMN Ecosystem is ECHAlliance Ecosystem of the Month – September

27 Aug 2025
This month we are featuring our Germany - Medical Valley EMN Ecosystem as our Ecosystem of the Month.

Manetu, a global leader in policy-based governance and knowledge protection

26 Aug 2025
Operating worldwide, Manetu partners with enterprises, technology providers, and standards bodies to shape the future of AI governance. From financial...

CTS: your go-to growth accelerator dedicated to healthtech startups

26 Aug 2025
Leveraging a global network of entrepreneurs, scientists, investors, and industry leaders in technology and life sciences, CTS’s mission is to catalyz...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *